Combined Corneal Transplant, Glaucoma Drainage Implantation, and Pars Plana Vitrectomy Outcomes in a Pediatric

Kelley J Bohm1, Alvaro Fernandez-Vega, Luis Acaba-Berrocal

  • 1Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago in Chicago, Chicago, IL.

Cornea
|February 4, 2022
PubMed

Insights

Combined eye surgeries including corneal transplants, glaucoma drainage devices (GDI), and pars plana vitrectomy (PPV) show effectiveness in pediatric patients. However, careful patient selection is crucial due to a high complication rate.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Corneal Transplantation
  • Glaucoma Management
  • Retinal Surgery

Background:

  • Combined glaucoma drainage device (GDI), pars plana vitrectomy (PPV), and corneal transplantation are established in adults.
  • Limited data exists on the outcomes of these combined procedures in pediatric populations.

Purpose of the Study:

  • To evaluate the safety and outcomes of concurrent GDI and/or PPV with corneal transplantation in patients aged 18 years and younger.
  • To assess vision, intraocular pressure, and complication rates in pediatric patients undergoing combined eye surgeries.

Main Methods:

  • Retrospective chart review of pediatric patients (0-18 years) from 2003-2017.
  • Inclusion criteria: corneal transplants or keratoprosthesis combined with GDI and/or PPV.
  • Primary outcomes: vision, intraocular pressure (IOP), cup-to-disc ratio (C/D); Secondary outcomes: repeat surgeries, complications.

Main Results:

  • 36 pediatric patients (mean age 8.4 years) with a mean follow-up of 49.7 months were analyzed.
  • 48% of patients receiving all three procedures (corneal surgery, GDI, PPV) showed improved vision (avg. 0.9 lines).
  • Average IOP decreased by -7.2 mm Hg across all groups; 53% of patients experienced complications.

Conclusions:

  • Combined keratoplasty, GDI, and PPV appear effective for complex pediatric eye conditions.
  • High complication rates necessitate careful surgical candidacy assessment in this young, vulnerable population.
  • Further research may be needed to optimize outcomes and minimize risks.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
741
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
947
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
874